Catestatin peptide of chromogranin A as a potential new target for several risk factors management in the course of metabolic syndrome.
Biomed Pharmacother. 2021 Feb;134:111113. doi: 10.1016/j.biopha.2020.111113. Epub 2020 Dec 16.
Biomed Pharmacother. 2021.
PMID: 33341043
Free article.
Review.